Compile Data Set for Download or QSAR
maximum 50k data
Found 204 with Last Name = 'myers' and Initial = 'mr'
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111966(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-benz...)
Affinity DataKi:  1nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM12594(4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXO...)
Affinity DataKi:  1nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM12594(4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXO...)
Affinity DataKi:  1.30nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111958(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-b...)
Affinity DataKi:  3nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111955(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-b...)
Affinity DataKi:  10nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  12nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  12nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111963(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-bromo-1H-be...)
Affinity DataKi:  17nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  21nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111957(1-(4-Amino-quinazolin-7-ylmethyl)-4-(5-chloro-1H-i...)
Affinity DataKi:  24nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111965(4-[4-(6-Chloro-1H-benzoimidazol-2-ylmethyl)-2-oxo-...)
Affinity DataKi:  40nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111955(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-b...)
Affinity DataKi:  42nMAssay Description:Tested for inhibitory activity against Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090605(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  59nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090600(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  97nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111960(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-methyl-1H-b...)
Affinity DataKi:  120nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090597(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  140nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090595(CHEMBL47654 | N-[2-(2-Amino-pyridin-4-yl)-ethyl]-2...)
Affinity DataKi:  140nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090604(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  160nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090596(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  170nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090613(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  250nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090615(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  270nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111961(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1-me...)
Affinity DataKi:  290nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090594(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  340nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111956(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-i...)
Affinity DataKi:  390nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090609(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  430nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090611(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  620nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090603(CHEMBL295515 | N-[2-(2-Amino-thiazol-4-yl)-ethyl]-...)
Affinity DataKi:  620nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111967(1-(4-Amino-quinazolin-7-ylmethyl)-4-(5-chloro-benz...)
Affinity DataKi:  1.20E+3nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111964(1-(4-Amino-quinazolin-7-ylmethyl)-4-(1H-benzoimida...)
Affinity DataKi:  1.20E+3nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111962(1-(4-Amino-quinazolin-7-ylmethyl)-4-(5-chloro-benz...)
Affinity DataKi:  1.20E+3nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111959(3-[4-(6-Chloro-1H-benzoimidazol-2-ylmethyl)-2-oxo-...)
Affinity DataKi: >1.20E+3nMAssay Description:Inhibition of Coagulation factor XaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090614(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090598(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090612(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090599((S)-2-{2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090608(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090610(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090607(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090602((R)-2-{2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090601(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090606(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111957(1-(4-Amino-quinazolin-7-ylmethyl)-4-(5-chloro-1H-i...)
Affinity DataKi: >2.90E+3nMAssay Description:Tested for inhibitory activity against trypsinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >2.90E+3nMAssay Description:Compound was evaluated for the inhibitory activity against trypsin.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >2.90E+3nMAssay Description:Compound was evaluated for the inhibitory activity against trypsinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111955(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-b...)
Affinity DataKi: >2.90E+3nMAssay Description:Tested for inhibitory activity against trypsinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111958(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-b...)
Affinity DataKi: >2.90E+3nMAssay Description:Tested for inhibitory activity against trypsinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111958(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-b...)
Affinity DataKi: >4.00E+3nMAssay Description:Tested for inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111955(1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-b...)
Affinity DataKi: >4.00E+3nMAssay Description:Tested for inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >4.00E+3nMAssay Description:Compound was evaluated for the inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >4.00E+3nMAssay Description:Compound was evaluated for the inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 204 total ) | Next | Last >>
Jump to: